Stocks · Health care · Pharmaceutical Preparations

HARROW, INC.

HROW Clue Score59
United States Fiscal year ends December CIK 0001360214 Results filed 10 Aug 2026

What the insiders did No buying or selling

By person

7 insiders · 0 transactions
158×

Mark L. Baum holds 158 times base salary in stock. $119.85M of shares against $754.91K in salary for 2025.

Salary from the company's own proxy. The shares are what Mark L. Baum last reported holding, valued at $40.00, the price Common Stock was last bought or sold at on the open market here, on 14 Aug 2026.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Mark L Baum
Chief Executive Officer
—
—
—
2,996,130
$119.85M
+40.2%
Andrew R. Boll
President and CFO
—
—
—
814,679
$32.59M
+43.4%
John P. Saharek
CEO & President, ImprimisRx
—
—
—
467,388
$18.70M
+56.0%
Opaleye Management Inc. entity
10% owner
—
—
—
59,428
$2.38M
−83.9%
Adrienne L Graves
Director
—
—
—
1,000
$40.00K
—
Lauren P Silvernail
Director
—
—
—
1,000
$40.00K
—
Amir Shojaei
Chief Scientific Officer
—
—
—
0
$0.00
—

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.